nodes	percent_of_prediction	percent_of_DWPC	metapath
Vapreotide—TACR1—vagus nerve—esophageal cancer	0.254	0.581	CbGeAlD
Vapreotide—SSTR2—digestive system—esophageal cancer	0.0434	0.0993	CbGeAlD
Vapreotide—TACR1—smooth muscle tissue—esophageal cancer	0.0365	0.0836	CbGeAlD
Vapreotide—TACR1—trachea—esophageal cancer	0.0335	0.0767	CbGeAlD
Vapreotide—TACR1—digestive system—esophageal cancer	0.0288	0.066	CbGeAlD
Vapreotide—TACR1—lung—esophageal cancer	0.0241	0.0551	CbGeAlD
Vapreotide—TACR1—lymph node—esophageal cancer	0.0165	0.0377	CbGeAlD
Vapreotide—SSTR5—Peptide ligand-binding receptors—CXCL2—esophageal cancer	0.00619	0.0111	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—SOX2—esophageal cancer	0.00612	0.011	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—ANXA1—esophageal cancer	0.00612	0.011	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—SST—esophageal cancer	0.00605	0.0108	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—GNG7—esophageal cancer	0.00592	0.0106	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—ADCYAP1—esophageal cancer	0.0059	0.0106	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—ANXA1—esophageal cancer	0.00575	0.0103	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—CXCL2—esophageal cancer	0.00571	0.0102	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—SST—esophageal cancer	0.00559	0.01	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—GNG7—esophageal cancer	0.00547	0.00981	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—GHRL—esophageal cancer	0.00545	0.00978	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—ANXA1—esophageal cancer	0.00531	0.00952	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—CXCL2—esophageal cancer	0.00522	0.00936	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—GNG7—esophageal cancer	0.00517	0.00927	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—SST—esophageal cancer	0.00516	0.00926	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—GHRL—esophageal cancer	0.00503	0.00903	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—ANXA1—esophageal cancer	0.00485	0.0087	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—CXCL2—esophageal cancer	0.00482	0.00864	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—SST—esophageal cancer	0.00476	0.00854	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—SST—esophageal cancer	0.00472	0.00847	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—ADCYAP1—esophageal cancer	0.00465	0.00834	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNG7—esophageal cancer	0.00462	0.00829	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—CXCL2—esophageal cancer	0.00449	0.00806	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—ANXA1—esophageal cancer	0.00448	0.00803	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—SST—esophageal cancer	0.00436	0.00781	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—ANXA1—esophageal cancer	0.00423	0.00759	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—ANXA1—esophageal cancer	0.00418	0.0075	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCL2—esophageal cancer	0.00415	0.00744	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—SST—esophageal cancer	0.00406	0.00729	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—GHRL—esophageal cancer	0.00401	0.0072	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—GHRL—esophageal cancer	0.00396	0.00711	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—ANXA1—esophageal cancer	0.00386	0.00692	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCL2—esophageal cancer	0.00383	0.00687	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—esophageal cancer	0.00379	0.00679	CbGpPWpGaD
Vapreotide—Desmopressin—PTGS1—esophageal cancer	0.00378	0.636	CrCbGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—SST—esophageal cancer	0.00375	0.00673	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—GHRL—esophageal cancer	0.00366	0.00656	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	0.00363	0.00651	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—ADCYAP1—esophageal cancer	0.00362	0.00649	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—esophageal cancer	0.00359	0.00644	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—GNG7—esophageal cancer	0.00359	0.00643	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—ANXA1—esophageal cancer	0.00356	0.00639	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—SST—esophageal cancer	0.00346	0.00621	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TLR4—esophageal cancer	0.00342	0.00613	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—GHRL—esophageal cancer	0.00337	0.00605	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—ADCYAP1—esophageal cancer	0.00334	0.00599	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—GNG7—esophageal cancer	0.00331	0.00594	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—ADCYAP1—esophageal cancer	0.00328	0.00589	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—NOS2—esophageal cancer	0.00325	0.00583	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CXCL2—esophageal cancer	0.00316	0.00567	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—ADCYAP1—esophageal cancer	0.00303	0.00544	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL2—esophageal cancer	0.00301	0.00541	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—GDI2—esophageal cancer	0.00301	0.0054	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.00297	0.00532	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—ANXA1—esophageal cancer	0.00294	0.00527	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CXCL2—esophageal cancer	0.00292	0.00523	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—RB1—esophageal cancer	0.00291	0.00522	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	0.00286	0.00513	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—SST—esophageal cancer	0.00286	0.00513	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—ANXA1—esophageal cancer	0.0028	0.00503	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—GHRL—esophageal cancer	0.00278	0.005	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—GDI2—esophageal cancer	0.00278	0.00498	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—SST—esophageal cancer	0.00273	0.00489	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—ANXA1—esophageal cancer	0.00271	0.00486	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—GHRL—esophageal cancer	0.00266	0.00477	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—SST—esophageal cancer	0.00264	0.00473	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—ADCYAP1—esophageal cancer	0.00263	0.00471	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—GNG7—esophageal cancer	0.00261	0.00467	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—GHRL—esophageal cancer	0.00257	0.00461	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—PTGS2—esophageal cancer	0.00239	0.00429	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—ADCYAP1—esophageal cancer	0.00239	0.00428	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.00233	0.00419	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—AKAP13—esophageal cancer	0.00233	0.00418	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CXCL2—esophageal cancer	0.0023	0.00412	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GDI2—esophageal cancer	0.00219	0.00392	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—KMT2D—esophageal cancer	0.00218	0.0039	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—CCND1—esophageal cancer	0.00216	0.00387	CbGpPWpGaD
Vapreotide—Desmopressin—PTGS2—esophageal cancer	0.00216	0.364	CrCbGaD
Vapreotide—SSTR2—GPCR downstream signaling—AKAP13—esophageal cancer	0.00215	0.00386	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—ANXA1—esophageal cancer	0.00213	0.00383	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PDE4D—esophageal cancer	0.00213	0.00382	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—AKAP13—esophageal cancer	0.00212	0.0038	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—SST—esophageal cancer	0.00208	0.00372	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—GNG7—esophageal cancer	0.00203	0.00364	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—GHRL—esophageal cancer	0.00202	0.00363	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.00202	0.00362	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—KMT2D—esophageal cancer	0.00201	0.0036	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PDE4D—esophageal cancer	0.00197	0.00353	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—AKAP13—esophageal cancer	0.00195	0.0035	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ADCYAP1—esophageal cancer	0.00194	0.00348	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PDE4D—esophageal cancer	0.00194	0.00347	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—GNG7—esophageal cancer	0.00187	0.00336	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—GNG7—esophageal cancer	0.00184	0.0033	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ADCYAP1—esophageal cancer	0.00179	0.00321	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PDE4D—esophageal cancer	0.00179	0.0032	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CXCL2—esophageal cancer	0.00179	0.0032	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—WWOX—esophageal cancer	0.00177	0.00318	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—MYC—esophageal cancer	0.00173	0.00311	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—GNG7—esophageal cancer	0.0017	0.00305	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—EGFR—esophageal cancer	0.00169	0.00304	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—AKAP13—esophageal cancer	0.00169	0.00304	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—FKBP1A—esophageal cancer	0.00169	0.00303	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—ANXA1—esophageal cancer	0.00166	0.00298	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—WIF1—esophageal cancer	0.00165	0.00296	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CXCL2—esophageal cancer	0.00165	0.00296	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—WWOX—esophageal cancer	0.00164	0.00294	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CXCL2—esophageal cancer	0.00162	0.00291	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—SST—esophageal cancer	0.00161	0.0029	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.00159	0.00285	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—KMT2D—esophageal cancer	0.00158	0.00284	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—GHRL—esophageal cancer	0.00157	0.00282	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—FKBP1A—esophageal cancer	0.00156	0.00279	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PDE4D—esophageal cancer	0.00155	0.00278	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AKAP13—esophageal cancer	0.00154	0.00276	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—ANXA1—esophageal cancer	0.00153	0.00275	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CSNK1A1—esophageal cancer	0.00152	0.00273	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—WIF1—esophageal cancer	0.00152	0.00273	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—ANXA1—esophageal cancer	0.00151	0.0027	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CXCL2—esophageal cancer	0.0015	0.00268	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—SST—esophageal cancer	0.00149	0.00267	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—GNG7—esophageal cancer	0.00147	0.00264	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—SST—esophageal cancer	0.00147	0.00263	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—GHRL—esophageal cancer	0.00145	0.00261	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—GHRL—esophageal cancer	0.00143	0.00256	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PFN1—esophageal cancer	0.00142	0.00255	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TP53—esophageal cancer	0.00142	0.00255	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ADCYAP1—esophageal cancer	0.00141	0.00253	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PDE4D—esophageal cancer	0.00141	0.00252	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CSNK1A1—esophageal cancer	0.0014	0.00252	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—ANXA1—esophageal cancer	0.00139	0.0025	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—SST—esophageal cancer	0.00135	0.00243	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—GNG7—esophageal cancer	0.00134	0.0024	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—GHRL—esophageal cancer	0.00132	0.00237	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PFN1—esophageal cancer	0.00131	0.00236	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CXCL2—esophageal cancer	0.0013	0.00233	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—WWOX—esophageal cancer	0.00129	0.00231	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ELMO1—esophageal cancer	0.00128	0.00229	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AKAP13—esophageal cancer	0.00125	0.00224	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—FKBP1A—esophageal cancer	0.00123	0.0022	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—ANXA1—esophageal cancer	0.00121	0.00216	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—WIF1—esophageal cancer	0.0012	0.00215	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ELMO1—esophageal cancer	0.00118	0.00212	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CXCL2—esophageal cancer	0.00118	0.00211	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—SST—esophageal cancer	0.00117	0.0021	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AKAP13—esophageal cancer	0.00115	0.00207	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HIST1H2BM—esophageal cancer	0.00115	0.00207	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—GHRL—esophageal cancer	0.00114	0.00205	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PDE4D—esophageal cancer	0.00114	0.00205	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CSNK1A1—esophageal cancer	0.00111	0.00198	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—ANXA1—esophageal cancer	0.0011	0.00197	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—GNG7—esophageal cancer	0.00109	0.00195	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—SST—esophageal cancer	0.00107	0.00191	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HIST1H2BM—esophageal cancer	0.00106	0.00191	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PDE4D—esophageal cancer	0.00105	0.00189	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.00105	0.00188	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—GHRL—esophageal cancer	0.00104	0.00186	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PFN1—esophageal cancer	0.00103	0.00186	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—XIAP—esophageal cancer	0.00102	0.00183	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.00102	0.00183	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—GNG7—esophageal cancer	0.001	0.0018	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CTNNA1—esophageal cancer	0.000963	0.00173	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CXCL2—esophageal cancer	0.000958	0.00172	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—XIAP—esophageal cancer	0.00094	0.00169	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ELMO1—esophageal cancer	0.000929	0.00167	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.00091	0.00163	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AKAP13—esophageal cancer	0.000908	0.00163	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PSME2—esophageal cancer	0.000895	0.00161	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PSME1—esophageal cancer	0.000895	0.00161	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ANXA1—esophageal cancer	0.000891	0.0016	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CTNNA1—esophageal cancer	0.000889	0.0016	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CXCL2—esophageal cancer	0.000884	0.00159	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SST—esophageal cancer	0.000866	0.00155	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NOTCH3—esophageal cancer	0.000844	0.00151	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—GHRL—esophageal cancer	0.000844	0.00151	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000838	0.0015	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—FBXW7—esophageal cancer	0.000831	0.00149	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PDE4D—esophageal cancer	0.000831	0.00149	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PSME1—esophageal cancer	0.000826	0.00148	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PSME2—esophageal cancer	0.000826	0.00148	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ANXA1—esophageal cancer	0.000822	0.00147	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SST—esophageal cancer	0.000799	0.00143	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GNG7—esophageal cancer	0.00079	0.00142	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—GHRL—esophageal cancer	0.000779	0.0014	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NOTCH3—esophageal cancer	0.000779	0.0014	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—FBXW7—esophageal cancer	0.000767	0.00138	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NOTCH2—esophageal cancer	0.000757	0.00136	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—XIAP—esophageal cancer	0.00074	0.00133	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CTNNA1—esophageal cancer	0.0007	0.00126	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NOTCH2—esophageal cancer	0.000699	0.00125	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CXCL2—esophageal cancer	0.000696	0.00125	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TGFBR2—esophageal cancer	0.000672	0.00121	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PSME2—esophageal cancer	0.00065	0.00117	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PSME1—esophageal cancer	0.00065	0.00117	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ANXA1—esophageal cancer	0.000647	0.00116	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SMAD4—esophageal cancer	0.000636	0.00114	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SST—esophageal cancer	0.000629	0.00113	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TGFBR2—esophageal cancer	0.00062	0.00111	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NOTCH3—esophageal cancer	0.000613	0.0011	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GHRL—esophageal cancer	0.000613	0.0011	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—FBXW7—esophageal cancer	0.000603	0.00108	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SMAD4—esophageal cancer	0.000587	0.00105	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NOTCH2—esophageal cancer	0.00055	0.000987	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HIF1A—esophageal cancer	0.00052	0.000933	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—KDR—esophageal cancer	0.000498	0.000893	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TGFBR2—esophageal cancer	0.000488	0.000876	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HIF1A—esophageal cancer	0.00048	0.000861	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NOTCH1—esophageal cancer	0.000469	0.000841	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SMAD4—esophageal cancer	0.000462	0.000829	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—KDR—esophageal cancer	0.000459	0.000824	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NOTCH1—esophageal cancer	0.000433	0.000776	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CREBBP—esophageal cancer	0.000425	0.000762	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—EGFR—esophageal cancer	0.000418	0.000749	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000399	0.000716	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CREBBP—esophageal cancer	0.000392	0.000704	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—EGFR—esophageal cancer	0.000385	0.000691	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NOS3—esophageal cancer	0.00038	0.000683	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HIF1A—esophageal cancer	0.000378	0.000678	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000368	0.000661	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PIK3CA—esophageal cancer	0.000362	0.00065	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—KDR—esophageal cancer	0.000362	0.000649	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ERBB2—esophageal cancer	0.000356	0.000638	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NOS3—esophageal cancer	0.000351	0.00063	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NOTCH1—esophageal cancer	0.000341	0.000611	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3CA—esophageal cancer	0.000334	0.0006	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ERBB2—esophageal cancer	0.000328	0.000589	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCND1—esophageal cancer	0.000314	0.000564	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CREBBP—esophageal cancer	0.000309	0.000554	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CDKN1A—esophageal cancer	0.000304	0.000546	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—EGFR—esophageal cancer	0.000303	0.000544	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCND1—esophageal cancer	0.00029	0.000521	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CA—esophageal cancer	0.00029	0.00052	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—EP300—esophageal cancer	0.000289	0.000519	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CDKN1A—esophageal cancer	0.000281	0.000504	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NOS3—esophageal cancer	0.000276	0.000496	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—EP300—esophageal cancer	0.000267	0.000479	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CA—esophageal cancer	0.000263	0.000472	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ERBB2—esophageal cancer	0.000259	0.000464	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MYC—esophageal cancer	0.000252	0.000452	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—EGFR—esophageal cancer	0.000247	0.000443	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MYC—esophageal cancer	0.000233	0.000418	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCND1—esophageal cancer	0.000228	0.00041	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—EGFR—esophageal cancer	0.000228	0.000408	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CDKN1A—esophageal cancer	0.000221	0.000396	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CA—esophageal cancer	0.000214	0.000384	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—EP300—esophageal cancer	0.00021	0.000377	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TP53—esophageal cancer	0.000207	0.000372	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CA—esophageal cancer	0.000198	0.000354	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TP53—esophageal cancer	0.000191	0.000343	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MYC—esophageal cancer	0.000183	0.000329	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—EGFR—esophageal cancer	0.000179	0.000322	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CA—esophageal cancer	0.000156	0.000279	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TP53—esophageal cancer	0.00015	0.00027	CbGpPWpGaD
